News

Ocugen Partner, Bharat Biotech, Announces Positive Immunogenicity and Safety Data From COVAXIN™ (BBV152), COVID-19 Candidate Vaccine, in Children 2 – 18 YEARS

COVAXIN™ whole virus inactivated vaccine generated broad antibody response comparable to those seen in a large phase 3 trial in adults...

Trait Biosciences Advances Innovative Water-Soluble Cannabinoid Technology, Delivering Key Milestones in Series A Financing and Appoints Dr. Hanny Kanafani as Vice President

VANCOUVER, BC, Dec. 30, 2021 /PRNewswire/ -- Trait Biosciences Inc., a leading cannabinoid biotechnology research organization, announced that it has...

error: Content is protected !!